Related references
Note: Only part of the references are listed.Walker 256 Tumor Growth Suppression by Crotoxin Involves Formyl Peptide Receptors and Lipoxin A(4)
Patricia Brigatte et al.
MEDIATORS OF INFLAMMATION (2016)
Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles
Long Binh Vong et al.
MOLECULAR PHARMACEUTICS (2016)
Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy
Mingzhen Zhang et al.
MOLECULAR THERAPY (2016)
Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity
Sahar A. Khaleel et al.
SCIENTIFIC REPORTS (2016)
Squalene Inhibits ATM-Dependent Signaling in γIR-Induced DNA Damage Response through Induction of Wip1 Phosphatase
Naoto Tatewaki et al.
PLOS ONE (2016)
NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain
Miriam D. Fonseca et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Weak direct and Strong indirect interactions are the mode of action of food factors
Tetsuya Konishi
FUNCTIONAL FOODS IN HEALTH AND DISEASE (2014)
Differential Effect of Schisandrin B Stereoisomers on ATR-Mediated DNA Damage Checkpoint Signaling
Naoto Tatewaki et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2013)
Effect of cyclooxygenase genotype and dietary fish oil on colonic eicosanoids in mice
Andrew P. Neilson et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Doxorubicin Induces Cytotoxicity through Upregulation of pERK-Dependent ATF3
Eun-Jung Park et al.
PLOS ONE (2012)
Effect of goniothalamin on the development of Ehrlich solid tumor in mice
Debora Barbosa Vendramini-Costa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Modulation of doxorubicin-induced genotoxicity by squalene in Balb/c mice
Bhilwade Hari Narayan et al.
FOOD & FUNCTION (2010)
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Inflammation and cancer: how friendly is the relationship for cancer patients?
Bharat B. Aggarwal et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Squalene Emulsions for Parenteral Vaccine and Drug Delivery
Christopher B. Fox
MOLECULES (2009)
COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics
M. H. McLean et al.
HISTOPATHOLOGY (2008)
Cyclooxygenase-1-selective inhibitors are attractive candidates for analgesics that do not cause gastric damage. design and in vitro/in vivo evaluation of a benzamide-type cyclooxygenase-1 selective inhibitor
Hiroki Kakuta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
X irradiation combined with TNF α-related apoptosis-inducing ligand (TRAIL) reduces hypoxic regions of human gastric adenocarcinoma xenografts in SCID mice
Momoko Takahashi et al.
JOURNAL OF RADIATION RESEARCH (2008)
Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells
Irene V. Bijnsdorp et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Ins and outs of dietary phytochemicals in cancer chemoprevention
Gian Luigi Russo
BIOCHEMICAL PHARMACOLOGY (2007)
Treatment combining X-irradiation and a ribonucleoside anticancer drug, TAS106, effectively suppresses the growth of tumor cells transplanted in mice
Hironobu Yasui et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Antioxidants attenuate multiple phases of formalin-induced nociceptive response in mice
A. Hacimuftuoglu et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
COX-2 and beyond: Approaches to prostaglandin inhibition in human disease
G FitzGerald
NATURE REVIEWS DRUG DISCOVERY (2003)
Squalene content and antioxidant activity of Terminalia catappa leaves and seeds
TF Ko et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Olive oil as a functional food: Epidemiology and nutritional approaches
AH Stark et al.
NUTRITION REVIEWS (2002)
Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation
T Sasamura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice
H Nakano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models
T Ochi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)